{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:59:44Z","timestamp":1793120384250,"version":"4.5.0"},"reference-count":361,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.5335","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T13:56:18Z","timestamp":1618235778000},"page":"e215335","source":"Crossref","is-referenced-by-count":214,"title":["Overdiagnosis of Attention-Deficit\/Hyperactivity Disorder in Children and Adolescents"],"prefix":"10.1001","volume":"4","author":[{"given":"Luise","family":"Kazda","sequence":"first","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Bell","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rae","family":"Thomas","sequence":"additional","affiliation":[{"name":"Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McGeechan","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sims","sequence":"additional","affiliation":[{"name":"Institute for Evidence-Based Healthcare, Bond University, Gold Coast, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Barratt","sequence":"additional","affiliation":[{"name":"Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"issue":"8","key":"zoi210181r1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/jcpp.2018.59.issue-8","article-title":"Has the attention deficit hyperactivity disorder phenotype become more common in children between 2004 and 2014? trends over 10 years from a Swedish general population sample.","volume":"59","author":"Rydell","year":"2018","journal-title":"J Child Psychol Psychiatry"},{"issue":"12","key":"zoi210181r2","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00127-012-0501-1","article-title":"Prevalence, incidence, and stimulant use of attention-deficit hyperactivity disorder in Taiwan, 1996-2005: a national population-based study.","volume":"47","author":"Chien","year":"2012","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"1","key":"zoi210181r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054714554617","article-title":"Prevalence, patient characteristics, and pharmacological treatment of children, adolescents, and adults diagnosed with ADHD in Sweden.","volume":"22","author":"Giacobini","year":"2018","journal-title":"J Atten Disord"},{"key":"zoi210181r4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.socscimed.2014.10.019","article-title":"The impending globalization of ADHD: notes on the expansion and growth of a medicalized disorder.","volume":"122","author":"Conrad","year":"2014","journal-title":"Soc Sci Med"},{"issue":"1","key":"zoi210181r5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","article-title":"Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003-2011.","volume":"53","author":"Visser","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"zoi210181r6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1471","article-title":"Twenty-year trends in diagnosed attention-deficit\/hyperactivity disorder among US children and adolescents, 1997-2016.","volume":"1","author":"Xu","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi210181r7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1542\/peds.2014-1778","article-title":"Overdiagnosis: how our compulsion for diagnosis may be harming children.","volume":"134","author":"Coon","year":"2014","journal-title":"Pediatrics"},{"issue":"6","key":"zoi210181r8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/NMD.0b013e318257c4b6","article-title":"DSM-5 further inflates attention deficit hyperactivity disorder.","volume":"200","author":"Batstra","year":"2012","journal-title":"J Nerv Ment Dis"},{"issue":"6","key":"zoi210181r9","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/dmcn.2012.54.issue-6","article-title":"Childhood emotional and behavioral problems: reducing overdiagnosis without risking undertreatment.","volume":"54","author":"Batstra","year":"2012","journal-title":"Dev Med Child Neurol"},{"key":"zoi210181r10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpr.2020.101889","article-title":"Diagnostic inflation in the DSM: A meta-analysis of changes in the stringency of psychiatric diagnosis from DSM-III to DSM-5.","volume":"80","author":"Fabiano","year":"2020","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"zoi210181r11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1037\/a0026582","article-title":"Is ADHD diagnosed in accord with diagnostic criteria? Overdiagnosis and influence of client gender on diagnosis.","volume":"80","author":"Bruchm\u00fcller","year":"2012","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"zoi210181r12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/archdischild-2016-310487","article-title":"Attention deficit hyperactivity disorder: overdiagnosed or diagnoses missed?","volume":"102","author":"Taylor","year":"2017","journal-title":"Arch Dis Child"},{"key":"zoi210181r13","doi-asserted-by":"publisher","first-page":"g7773","DOI":"10.1136\/bmj.g7773","article-title":"Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.","volume":"350","author":"Carter","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"zoi210181r14","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7326\/M18-0694","article-title":"Defining, estimating, and communicating overdiagnosis in cancer screening.","volume":"169","author":"Davies","year":"2018","journal-title":"Ann Intern Med"},{"key":"zoi210181r15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13034-016-0140-5","article-title":"Overdiagnosis of mental disorders in children and adolescents (in developed countries).","volume":"11","author":"Merten","year":"2017","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"9","key":"zoi210181r16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/archinternmed.2011.178","article-title":"Time trends in pulmonary embolism in the United States: evidence of overdiagnosis.","volume":"171","author":"Wiener","year":"2011","journal-title":"Arch Intern Med"},{"issue":"10015","key":"zoi210181r17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/S0140-6736(15)00472-9","article-title":"Harms of screening for abdominal aortic aneurysm: is there more to life than a 0.46% disease-specific mortality reduction?","volume":"387","author":"Johansson","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"zoi210181r18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7326\/M18-2645","article-title":"Recognizing the potential for overdiagnosis: are high-sensitivity cardiac troponin assays an example?","volume":"170","author":"Bell","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi210181r19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1047840X.2016.1082418","article-title":"Concept creep: psychology\u2019s expanding concepts of harm and pathology.","volume":"27","author":"Haslam","year":"2016","journal-title":"Psychol Inq"},{"issue":"1","key":"zoi210181r20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jaac.2014.10.014","article-title":"The impact of case definition on attention-deficit\/hyperactivity disorder prevalence estimates in community-based samples of school-aged children.","volume":"54","author":"McKeown","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210181r21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1087054715586571","article-title":"Is ADHD really increasing in youth?","volume":"22","author":"Safer","year":"2018","journal-title":"J Atten Disord"},{"issue":"22","key":"zoi210181r22","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa1806828","article-title":"Attention deficit-hyperactivity disorder and month of school enrollment.","volume":"379","author":"Layton","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi210181r23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmed-2017-110886","article-title":"Overdiagnosis: what it is and what it isn\u2019t.","volume":"23","author":"Brodersen","year":"2018","journal-title":"BMJ Evid Based Med"},{"issue":"4","key":"zoi210181r24","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/jep.12556","article-title":"Getting clearer on overdiagnosis.","volume":"22","author":"Rogers","year":"2016","journal-title":"J Eval Clin Pract"},{"key":"zoi210181r25","doi-asserted-by":"publisher","first-page":"f6172","DOI":"10.1136\/bmj.f6172","article-title":"Attention-deficit\/hyperactivity disorder: are we helping or harming?","volume":"347","author":"Thomas","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"zoi210181r26","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"zoi210181r28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032327","article-title":"Evidence of potential overdiagnosis and overtreatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents: protocol for a scoping review.","volume":"9","author":"Kazda","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"zoi210181r29","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/medethics-2015-102928","article-title":"A definition and ethical evaluation of overdiagnosis.","volume":"42","author":"Carter","year":"2016","journal-title":"J Med Ethics"},{"issue":"1","key":"zoi210181r30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13643-018-0707-8","article-title":"Technology-assisted title and abstract screening for systematic reviews: a retrospective evaluation of the Abstrackr machine learning tool.","volume":"7","author":"Gates","year":"2018","journal-title":"Syst Rev"},{"key":"zoi210181r31","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13643-015-0067-6","article-title":"Faster title and abstract screening? evaluating Abstrackr, a semi-automated online screening program for systematic reviewers.","volume":"4","author":"Rathbone","year":"2015","journal-title":"Syst Rev"},{"issue":"1","key":"zoi210181r33","doi-asserted-by":"publisher","first-page":"17029","DOI":"10.1038\/s41598-018-35048-5","article-title":"Trends and regional variations in the administrative prevalence of attention-deficit\/hyperactivity disorder among children and adolescents in Germany.","volume":"8","author":"Akmatov","year":"2018","journal-title":"Sci Rep"},{"issue":"2","key":"zoi210181r34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/070674371205700206","article-title":"Prevalence of prescribed attention-deficit hyperactivity disorder medications and diagnosis among Canadian preschoolers and school-age children: 1994-2007.","volume":"57","author":"Brault","year":"2012","journal-title":"Can J Psychiatry"},{"issue":"34","key":"zoi210181r35","first-page":"842","article-title":"Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit\/hyperactivity disorder\u2013United States, 2003.","volume":"54","author":"Centers for Disease Control and Prevention (CDC)","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"44","key":"zoi210181r36","first-page":"1439","article-title":"Increasing prevalence of parent-reported attention-deficit\/hyperactivity disorder among children\u2014United States, 2003 and 2007.","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"zoi210181r37","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4088\/JCP.14m09364","article-title":"Racial and ethnic disparities in parent-reported diagnosis of ADHD: National Survey of Children\u2019s Health (2003, 2007, and 2011).","volume":"77","author":"Collins","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"zoi210181r38","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1177\/1087054705280413","article-title":"Prevalence and correlates of ADHD symptoms in the national health interview survey.","volume":"9","author":"Cuffe","year":"2005","journal-title":"J Atten Disord"},{"issue":"7","key":"zoi210181r39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/DBP.0000000000000477","article-title":"A national profile of attention-deficit hyperactivity disorder diagnosis and treatment among US children aged 2 to 5 years.","volume":"38","author":"Danielson","year":"2017","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"zoi210181r40","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12887-017-0971-0","article-title":"Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade.","volume":"17","author":"Davidovitch","year":"2017","journal-title":"BMC Pediatr"},{"issue":"1","key":"zoi210181r41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/1087054716688534","article-title":"Diagnosis and treatment of ADHD in the United States: update by gender and race.","volume":"24","author":"Fairman","year":"2020","journal-title":"J Atten Disord"},{"issue":"2","key":"zoi210181r42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1207\/s15324826an1202_7","article-title":"Teachers\u2019 perceptions of the incidence and management of attention-deficit hyperactivity disorder.","volume":"12","author":"Havey","year":"2005","journal-title":"Appl Neuropsychol"},{"issue":"2","key":"zoi210181r43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1177\/1087054715613441","article-title":"ADHD in the United Kingdom: regional and socioeconomic variations in incidence rates amongst children and adolescents (2004-2013).","volume":"22","author":"Hire","year":"2018","journal-title":"J Atten Disord"},{"issue":"4","key":"zoi210181r44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095014","article-title":"Epidemiology of treated attention-deficit\/hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study.","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"zoi210181r45","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s00787-008-1006-z","article-title":"How often are German children and adolescents diagnosed with ADHD? prevalence based on the judgment of health care professionals: results of the German health and examination survey (KiGGS).","volume":"17","author":"Huss","year":"2008","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"zoi210181r46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/archdischild-2017-314470","article-title":"Attention-deficit\/hyperactivity disorder: variation by socioeconomic deprivation.","volume":"104","author":"Prasad","year":"2019","journal-title":"Arch Dis Child"},{"issue":"2","key":"zoi210181r47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2165\/00023210-200216020-00005","article-title":"Is attention deficit hyperactivity disorder increasing among girls in the US? trends in diagnosis and the prescribing of stimulants.","volume":"16","author":"Robison","year":"2002","journal-title":"CNS Drugs"},{"issue":"2","key":"zoi210181r48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2105\/AJPH.92.2.231","article-title":"Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.","volume":"92","author":"Rowland","year":"2002","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi210181r49","doi-asserted-by":"publisher","first-page":"e601","DOI":"10.1542\/peds.2005-1308","article-title":"Who receives a diagnosis of attention-deficit\/ hyperactivity disorder in the United States elementary school population?","volume":"117","author":"Schneider","year":"2006","journal-title":"Pediatrics"},{"issue":"36","key":"zoi210181r50","first-page":"615","article-title":"The changing prevalence of attention-deficit\/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Co in the German State of Hesse, 2000-2007.","volume":"107","author":"Schubert","year":"2010","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"zoi210181r51","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1176\/appi.ps.201400364","article-title":"Prevalence and diagnosis rates of childhood ADHD among racial-ethnic groups in a public mental health system.","volume":"67","author":"Siegel","year":"2016","journal-title":"Psychiatr Serv"},{"issue":"2","key":"zoi210181r52","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00431-006-0299-5","article-title":"Variations in prevalence of attention deficit hyperactivity disorder worldwide.","volume":"166","author":"Skounti","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"4","key":"zoi210181r53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1542\/peds.2019-0811","article-title":"Prevalence and trends of developmental disabilities among children in the United States: 2009-2017.","volume":"144","author":"Zablotsky","year":"2019","journal-title":"Pediatrics"},{"issue":"9","key":"zoi210181r54","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/archpedi.161.9.857","article-title":"Prevalence, recognition, and treatment of attention-deficit\/hyperactivity disorder in a national sample of US children.","volume":"161","author":"Froehlich","year":"2007","journal-title":"Arch Pediatr Adolesc Med"},{"key":"zoi210181r55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2296-11-11","article-title":"The effects of patient characteristics on ADHD diagnosis and treatment: a factorial study of family physicians.","volume":"11","author":"Morley","year":"2010","journal-title":"BMC Fam Pract"},{"issue":"70","key":"zoi210181r56","first-page":"1","article-title":"Attention deficit hyperactivity disorder among children aged 5-17 years in the United States, 1998-2009.","author":"Akinbami","year":"2011","journal-title":"NCHS Data Brief"},{"issue":"3","key":"zoi210181r57","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/01425692.2013.776933","article-title":"Medicus interruptus in the behaviour of children in disadvantaged contexts in Scotland.","volume":"35","author":"Allan","year":"2014","journal-title":"Br J Sociol Educ"},{"issue":"3","key":"zoi210181r59","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/070674370104600307","article-title":"Attention-deficit hyperactivity disorder in Manitoba children: medical diagnosis and psychostimulant treatment rates.","volume":"46","author":"Brownell","year":"2001","journal-title":"Can J Psychiatry"},{"issue":"1","key":"zoi210181r60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1753-2000-7-34","article-title":"The prevalence and incidence, resource use and financial costs of treating people with attention deficit\/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).","volume":"7","author":"Holden","year":"2013","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"8","key":"zoi210181r61","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1089\/cap.2016.0196","article-title":"Treated prevalence of attention-deficit\/hyperactivity disorder increased from 2009 to 2015 among school-aged children and adolescents in the United States.","volume":"27","author":"Nyarko","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"zoi210181r62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/DBP.0000000000000626","article-title":"The association between race\/ethnicity and socioeconomic factors and the diagnosis and treatment of children with attention-deficit hyperactivity disorder.","volume":"40","author":"Bax","year":"2019","journal-title":"J Dev Behav Pediatr"},{"issue":"1","key":"zoi210181r63","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1542\/peds.2012-2390","article-title":"Racial and ethnic disparities in ADHD diagnosis from kindergarten to eighth grade.","volume":"132","author":"Morgan","year":"2013","journal-title":"Pediatrics"},{"key":"zoi210181r64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ssresearch.2016.06.018","article-title":"Attention-deficit\/hyperactivity disorder severity, diagnosis, and later academic achievement in a national sample.","volume":"61","author":"Owens","year":"2017","journal-title":"Soc Sci Res"},{"issue":"3","key":"zoi210181r65","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-0407","article-title":"Racial and ethnic disparities in ADHD diagnosis and treatment.","volume":"138","author":"Coker","year":"2016","journal-title":"Pediatrics"},{"issue":"3","key":"zoi210181r66","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/2013.jamapediatrics.401","article-title":"Recent trends in childhood attention-deficit\/hyperactivity disorder.","volume":"167","author":"Getahun","year":"2013","journal-title":"JAMA Pediatr"},{"issue":"1","key":"zoi210181r67","first-page":"13","article-title":"The potential for sociocultural factors in the diagnosis of ADHD in children.","volume":"112","author":"Reyes","year":"2013","journal-title":"WMJ"},{"issue":"9","key":"zoi210181r68","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1007\/s00787-018-1180-6","article-title":"Age level vs grade level for the diagnosis of ADHD and neurodevelopmental disorders.","volume":"27","author":"Bonati","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r69","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jhealeco.2010.06.003","article-title":"The importance of relative standards in ADHD diagnoses: evidence based on exact birth dates.","volume":"29","author":"Elder","year":"2010","journal-title":"J Health Econ"},{"issue":"5","key":"zoi210181r70","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.jhealeco.2010.07.005","article-title":"Measuring inappropriate medical diagnosis and treatment in survey data: the case of ADHD among school-age children.","volume":"29","author":"Evans","year":"2010","journal-title":"J Health Econ"},{"issue":"8","key":"zoi210181r71","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jcpp.12229","article-title":"Relative immaturity and ADHD: findings from nationwide registers, parent- and self-reports.","volume":"55","author":"Halldner","year":"2014","journal-title":"J Child Psychol Psychiatry"},{"issue":"11","key":"zoi210181r72","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00787-018-1229-6","article-title":"Relative age and ADHD symptoms, diagnosis and medication: a systematic review.","volume":"28","author":"Holland","year":"2019","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"zoi210181r73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1177\/1403494817708080","article-title":"ADHD treatment and diagnosis in relation to children\u2019s birth month: nationwide cohort study from Norway.","volume":"45","author":"Karlstad","year":"2017","journal-title":"Scand J Public Health"},{"issue":"7","key":"zoi210181r74","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1503\/cmaj.111619","article-title":"Influence of relative age on diagnosis and treatment of attention-deficit\/hyperactivity disorder in children.","volume":"184","author":"Morrow","year":"2012","journal-title":"CMAJ"},{"issue":"11","key":"zoi210181r75","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S2215-0366(17)30394-2","article-title":"Relative age within the school year and diagnosis of attention-deficit hyperactivity disorder: a nationwide population-based study.","volume":"4","author":"Sayal","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"zoi210181r76","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.labeco.2016.05.018","article-title":"The youngest get the pill: ADHD misdiagnosis in Germany, its regional correlates and international comparison.","volume":"43","author":"Schwandt","year":"2016","journal-title":"Labour Econ"},{"issue":"4","key":"zoi210181r77","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jcpp.2019.60.issue-4","article-title":"Attention deficit hyperactivity disorder late birthdate effect common in both high and low prescribing international jurisdictions: a systematic review.","volume":"60","author":"Whitely","year":"2019","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"zoi210181r78","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.econlet.2012.08.008","article-title":"Relative standards in ADHD diagnoses: the role of specialist behavior.","volume":"117","author":"Dalsgaard","year":"2012","journal-title":"Econ Lett"},{"issue":"5","key":"zoi210181r79","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/00004583-199505000-00015","article-title":"Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample.","volume":"34","author":"Baumgaertel","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi210181r80","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00787-008-1007-y","article-title":"How often do children meet ICD-10\/DSM-IV criteria of attention deficit-\/hyperactivity disorder and hyperkinetic disorder? parent-based prevalence rates in a national sample\u2013results of the BELLA study.","volume":"17","author":"D\u00f6pfner","year":"2008","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"zoi210181r81","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.comppsych.2012.06.001","article-title":"Agreement between Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, and the proposed DSM-V attention deficit hyperactivity disorder diagnostic criteria: an exploratory study.","volume":"54","author":"Ghanizadeh","year":"2013","journal-title":"Compr Psychiatry"},{"issue":"11","key":"zoi210181r82","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1176\/ajp.151.11.1673","article-title":"DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.","volume":"151","author":"Lahey","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"4","key":"zoi210181r83","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00004583-199007000-00017","article-title":"Comparison of DSM-III and DSM-III-R diagnoses for prepubertal children: changes in prevalence and validity.","volume":"29","author":"Lahey","year":"1990","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r84","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/jcpp.2006.47.issue-5","article-title":"Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit\/hyperactivity disorder among younger children.","volume":"47","author":"Lahey","year":"2006","journal-title":"J Child Psychol Psychiatry"},{"issue":"1","key":"zoi210181r85","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/jcpp.2008.49.issue-1","article-title":"Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder.","volume":"49","author":"Lee","year":"2008","journal-title":"J Child Psychol Psychiatry"},{"issue":"4","key":"zoi210181r86","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1192\/bjp.168.4.486","article-title":"The diagnosis and prevalence of hyperactivity in Chinese schoolboys.","volume":"168","author":"Leung","year":"1996","journal-title":"Br J Psychiatry"},{"issue":"5","key":"zoi210181r87","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1097\/00004583-198909000-00015","article-title":"Are ADDH and ADHD the same or different?","volume":"28","author":"Newcorn","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210181r88","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004703-199404000-00004","article-title":"Parent and teacher ratings of attention-deficit hyperactivity disorder symptoms: implications for case identification.","volume":"15","author":"Newcorn","year":"1994","journal-title":"J Dev Behav Pediatr"},{"issue":"4","key":"zoi210181r89","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4088\/JCP.13m08638","article-title":"Attention-deficit\/hyperactivity disorder symptom expression: a comparison of individual age at onset using item response theory.","volume":"75","author":"Peyre","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"zoi210181r90","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis.","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"4","key":"zoi210181r91","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1542\/peds.2014-3482","article-title":"Prevalence of attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis.","volume":"135","author":"Thomas","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"zoi210181r92","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.jaac.2014.03.005","article-title":"Impact of the DSM-5 attention-deficit\/hyperactivity disorder age-of-onset criterion in the US adolescent population.","volume":"53","author":"Vande Voort","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210181r93","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/00004583-199603000-00013","article-title":"Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.","volume":"35","author":"Wolraich","year":"1996","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210181r94","first-page":"210","article-title":"Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.","volume":"49","author":"Polanczyk","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210181r95","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1176\/appi.ajp.2017.17030298","article-title":"Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25.","volume":"175","author":"Sibley","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi210181r96","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1363459304038795","article-title":"Medicalization, ambivalence and social control: mothers\u2019 descriptions of educators and ADD\/ADHD.","volume":"8","author":"Malacrida","year":"2004","journal-title":"Health (London)"},{"issue":"11","key":"zoi210181r97","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1176\/ajp.149.11.1539","article-title":"Cross-cultural differences in rating hyperactive-disruptive behaviors in children.","volume":"149","author":"Mann","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"5","key":"zoi210181r98","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jaac.2018.02.012","article-title":"Has the prevalence of child and adolescent mental disorders in Australia changed between 1998 and 2013 to 2014?","volume":"57","author":"Sawyer","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi210181r99","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/jcpp.12273","article-title":"Trends in parent- and teacher-rated emotional, conduct and ADHD problems and their impact in prepubertal children in Great Britain: 1999-2008.","volume":"56","author":"Sellers","year":"2015","journal-title":"J Child Psychol Psychiatry"},{"issue":"3","key":"zoi210181r100","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/00004703-199806000-00003","article-title":"Examination of DSM-IV criteria for attention deficit\/hyperactivity disorder in a county-wide sample.","volume":"19","author":"Wolraich","year":"1998","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"zoi210181r101","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/camh.2019.24.issue-2","article-title":"Investigating the agreement between the clinician and research diagnosis of attention deficit hyperactivity disorder and how it changes over time; a clinical cohort study.","volume":"24","author":"Longridge","year":"2019","journal-title":"Child Adolesc Ment Health"},{"issue":"2","key":"zoi210181r102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00787-017-1029-4","article-title":"Characteristics of undiagnosed children with parent-reported ADHD behaviour.","volume":"27","author":"Madsen","year":"2018","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r103","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1177\/1087054719837746","article-title":"Psychosocial burden of undiagnosed persistent ADHD symptoms in 12-year-old children: a population-based birth cohort study.","volume":"25","author":"Okumura","year":"2021","journal-title":"J Atten Disord"},{"issue":"4","key":"zoi210181r104","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1023391708850","article-title":"Agreement and stability of teacher rating scales for assessing ADHD in preschoolers.","volume":"30","author":"Loughran","year":"2003","journal-title":"Early Child Educ J"},{"issue":"10","key":"zoi210181r105","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1177\/070674370104601005","article-title":"Studying the epidemiology of attention-deficit hyperactivity disorder: screening method and pilot results.","volume":"46","author":"Rowland","year":"2001","journal-title":"Can J Psychiatry"},{"issue":"2","key":"zoi210181r106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10566-013-9194-1","article-title":"Elementary and middle school teacher perceptions of attention-deficit\/hyperactivity disorder prevalence.","volume":"42","author":"Fabiano","year":"2013","journal-title":"Child Youth Care Forum"},{"issue":"1","key":"zoi210181r107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1753-2000-2-32","article-title":"Assessing the diagnostic accuracy of the identification of hyperkinetic disorders following the introduction of government guidelines in England.","volume":"2","author":"Foreman","year":"2008","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"6","key":"zoi210181r108","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00787-013-0514-7","article-title":"Subthreshold attention deficit hyperactivity in children and adolescents: a systematic review.","volume":"23","author":"Bal\u00e1zs","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r109","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m11870","article-title":"Further evidence of morbidity and dysfunction associated with subsyndromal ADHD in clinically referred children.","volume":"79","author":"Biederman","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"zoi210181r110","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00787-009-0755-7","article-title":"Full syndrome and subthreshold attention-deficit\/hyperactivity disorder in a Korean community sample: comorbidity and temperament findings.","volume":"18","author":"Cho","year":"2009","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"zoi210181r111","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1037\/a0018610","article-title":"Classification of behavior disorders in adolescence: scaling methods, predictive validity, and gender differences.","volume":"119","author":"Fergusson","year":"2010","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"zoi210181r112","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00004583-199504000-00015","article-title":"Predictive validity of categorically and dimensionally scored measures of disruptive childhood behaviors.","volume":"34","author":"Fergusson","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"zoi210181r113","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jcpp.1997.38.issue-6","article-title":"Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood.","volume":"38","author":"Fergusson","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"issue":"8","key":"zoi210181r114","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00787-013-0501-z","article-title":"Subthreshold attention-deficit\/hyperactivity disorder is associated with functional impairments across domains: a comprehensive analysis in a large-scale community study.","volume":"23","author":"Hong","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"zoi210181r115","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.psychres.2019.02.003","article-title":"Are subsyndromal manifestations of attention deficit hyperactivity disorder morbid in children? a systematic qualitative review of the literature with meta-analysis.","volume":"274","author":"Kirova","year":"2019","journal-title":"Psychiatry Res"},{"key":"zoi210181r116","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.lindif.2016.04.003","article-title":"A longitudinal study of the association between inattention, hyperactivity and impulsivity and children\u2019s academic attainment at age 11.","volume":"53","author":"Merrell","year":"2017","journal-title":"Learn Individ Differ"},{"issue":"6","key":"zoi210181r117","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/acps.2016.134.issue-6","article-title":"Subthreshold and threshold attention deficit hyperactivity disorder symptoms in childhood: psychosocial outcomes in adolescence in boys and girls.","volume":"134","author":"Nor\u00e9n Selinus","year":"2016","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"zoi210181r118","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jaac.2015.02.007","article-title":"Childhood behavior problems and academic outcomes in adolescence: longitudinal population-based study.","volume":"54","author":"Sayal","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210181r119","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/1359104513489979","article-title":"Attention-deficit hyperactivity disorder (ADHD) in the early years: diagnostic issues and educational relevance.","volume":"19","author":"Schmiedeler","year":"2014","journal-title":"Clin Child Psychol Psychiatry"},{"issue":"1","key":"zoi210181r120","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/cdev.2002.73.issue-1","article-title":"The ADHD spectrum and everyday life: experience sampling of adolescent moods, activities, smoking, and drinking.","volume":"73","author":"Whalen","year":"2002","journal-title":"Child Dev"},{"issue":"1","key":"zoi210181r121","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jcpp.2011.53.issue-1","article-title":"Childhood attention-deficit hyperactivity disorder as an extreme of a continuous trait: a quantitative genetic study of 8,500 twin pairs.","volume":"53","author":"Larsson","year":"2012","journal-title":"J Child Psychol Psychiatry"},{"issue":"6","key":"zoi210181r122","doi-asserted-by":"publisher","first-page":"712","DOI":"10.4088\/JCP.14m09555","article-title":"A 4-year follow-up of attention-deficit\/hyperactivity disorder in a population sample.","volume":"76","author":"Lecendreux","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"zoi210181r123","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.18m12642","article-title":"A 9-year follow-up of attention-deficit\/hyperactivity disorder in a population sample.","volume":"80","author":"Lecendreux","year":"2019","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"zoi210181r124","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1080\/j.1440-1614.2006.01863.x","article-title":"The latent structure of attention-deficit\/hyperactivity disorder: a taxometric analysis.","volume":"40","author":"Haslam","year":"2006","journal-title":"Aust N Z J Psychiatry"},{"issue":"8","key":"zoi210181r125","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1097\/00004583-199808000-00015","article-title":"Latent class and factor analysis of DSM-IV ADHD: a twin study of female adolescents.","volume":"37","author":"Hudziak","year":"1998","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"zoi210181r126","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1097\/00004583-199706000-00009","article-title":"Attention-deficit hyperactivity disorder: a category or a continuum? genetic analysis of a large-scale twin study.","volume":"36","author":"Levy","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"zoi210181r127","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1097\/CHI.0b013e3181ba3dbb","article-title":"Maternal ratings of attention problems in ADHD: evidence for the existence of a continuum.","volume":"48","author":"Lubke","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210181r128","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1037\/a0021405","article-title":"Does attention-deficit\/hyperactivity disorder have a dimensional latent structure? a taxometric analysis.","volume":"120","author":"Marcus","year":"2011","journal-title":"J Abnorm Psychol"},{"issue":"12","key":"zoi210181r129","first-page":"979","article-title":"Understanding attention deficit hyperactivity disorder as a continuum.","volume":"62","author":"McLennan","year":"2016","journal-title":"Can Fam Physician"},{"issue":"2","key":"zoi210181r130","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00787-014-0553-8","article-title":"The increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparison.","volume":"24","author":"Atladottir","year":"2015","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"10","key":"zoi210181r131","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1176\/appi.ps.201400145","article-title":"State variation in increased ADHD prevalence: links to NCLB school accountability and state medication laws.","volume":"66","author":"Fulton","year":"2015","journal-title":"Psychiatr Serv"},{"issue":"2","key":"zoi210181r132","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.acap.2012.01.003","article-title":"Trends in attention deficit hyperactivity disorder ambulatory diagnosis and medical treatment in the United States, 2000-2010.","volume":"12","author":"Garfield","year":"2012","journal-title":"Acad Pediatr"},{"issue":"7","key":"zoi210181r133","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1377\/hlthaff.2015.1423","article-title":"Ten-year trends in treatment services for children with attention deficit hyperactivity disorder enrolled in Medicaid.","volume":"35","author":"Hoagwood","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"zoi210181r134","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/JCP.0000000000000980","article-title":"Potential explanations for increasing methylphenidate use in children and adolescents with attention-deficit\/hyperactivity disorder in Germany from 2004 to 2013.","volume":"39","author":"Langner","year":"2019","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"zoi210181r135","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/000992289903800402","article-title":"National trends in the prevalence of attention-deficit\/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.","volume":"38","author":"Robison","year":"1999","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"zoi210181r136","doi-asserted-by":"crossref","DOI":"10.1111\/appy.12289","article-title":"Patient and provider characteristics related with prescribing of ADHD medication: nationwide health insurance claims database study in Korea.","volume":"10","author":"Song","year":"2018","journal-title":"Asia Pac Psychiatry"},{"key":"zoi210181r137","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2016045","article-title":"Prescribing patterns for attention deficit hyperactivity disorder medications among children and adolescents in Korea, 2007-2011.","volume":"38","author":"Song","year":"2016","journal-title":"Epidemiol Health"},{"issue":"14","key":"zoi210181r138","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1177\/1087054718799930","article-title":"Addressing discrepancies between ADHD prevalence and case identification estimates among U.S. children utilizing NSCH 2007-2012.","volume":"23","author":"Song","year":"2019","journal-title":"J Atten Disord"},{"issue":"8","key":"zoi210181r139","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1176\/ps.2006.57.8.1091","article-title":"Datapoints: trends in ADHD and stimulant use among children, 1993-2003.","volume":"57","author":"Toh","year":"2006","journal-title":"Psychiatr Serv"},{"issue":"12","key":"zoi210181r140","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1177\/0706743717714468","article-title":"Temporal trends in the prevalence and incidence of diagnosed ADHD in children and young adults between 1999 and 2012 in Canada: a data linkage study.","volume":"62","author":"Vasiliadis","year":"2017","journal-title":"Can J Psychiatry"},{"issue":"6","key":"zoi210181r141","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1017\/S2045796016000500","article-title":"Prevalence rates of youths diagnosed with and medicated for ADHD in a nationwide survey in Taiwan from 2000 to 2011.","volume":"26","author":"Wang","year":"2017","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"1","key":"zoi210181r142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1345\/aph.1K143","article-title":"Utilization of pharmacologic treatment in youths with attention deficit\/hyperactivity disorder in Medicaid database.","volume":"42","author":"Winterstein","year":"2008","journal-title":"Ann Pharmacother"},{"issue":"2","key":"zoi210181r143","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1177\/1087054719843179","article-title":"Drug prescriptions for children with ADHD in Japan: a study based on health insurance claims data between 2005 and 2015.","volume":"24","author":"Yoshida","year":"2020","journal-title":"J Atten Disord"},{"issue":"12","key":"zoi210181r144","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/archpedi.153.12.1257","article-title":"Psychotherapeutic medication patterns for youths with attention-deficit\/hyperactivity disorder.","volume":"153","author":"Zito","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"zoi210181r145","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1177\/0009922812439621","article-title":"Attention-deficit\/hyperactivity disorder among children and adolescents in the United States: trend in diagnosis and use of pharmacotherapy by gender.","volume":"51","author":"Sclar","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"key":"zoi210181r146","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.112792","article-title":"Trends in incidence rates of diagnosed attention-deficit\/hyperactivity disorder (ADHD) over 12 years in Taiwan: a nationwide population-based study.","volume":"284","author":"Huang","year":"2020","journal-title":"Psychiatry Res"},{"issue":"3","key":"zoi210181r147","doi-asserted-by":"publisher","first-page":"e334","DOI":"10.4088\/JCP.14m09094","article-title":"Time trends in incidence rates of diagnosed attention-deficit\/hyperactivity disorder across 16 years in a nationwide Danish registry study.","volume":"76","author":"Mohr Jensen","year":"2015","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"zoi210181r148","doi-asserted-by":"publisher","first-page":"6397","DOI":"10.1038\/s41598-020-63342-8","article-title":"Temporal trends and geographical variability of the prevalence and incidence of attention deficit\/hyperactivity disorder diagnoses among children in Catalonia, Spain.","volume":"10","author":"P\u00e9rez-Crespo","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"zoi210181r149","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3325\/cmj.2015.56.159","article-title":"Prevalence and incidence of attention-deficit\/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective.","volume":"56","author":"\u0160tuhec","year":"2015","journal-title":"Croat Med J"},{"key":"zoi210181r150","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jhealeco.2014.05.005","article-title":"Consequences of ADHD medication use for children\u2019s outcomes.","volume":"37","author":"Dalsgaard","year":"2014","journal-title":"J Health Econ"},{"issue":"5-6","key":"zoi210181r151","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.cnr.2005.09.010","article-title":"Refining the diagnoses of inattention and overactivity syndromes: a reanalysis of the multimodal treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder.","volume":"5","author":"Santosh","year":"2005","journal-title":"Clin Neurosci Res"},{"issue":"6","key":"zoi210181r152","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1017\/S2045796014000523","article-title":"Prevalence of severe ADHD: an epidemiological study in the Italian regions of Tuscany and Latium.","volume":"24","author":"Donfrancesco","year":"2015","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"5","key":"zoi210181r153","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.euroneuro.2017.03.002","article-title":"Trends in ADHD medication use in children and adolescents in five western countries, 2005-2012.","volume":"27","author":"Bachmann","year":"2017","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"zoi210181r154","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/cap.2019.0032","article-title":"Psychotropic medication prescription rates and trends for New Zealand children and adolescents 2008-2016.","volume":"30","author":"Barczyk","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"zoi210181r155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010508","article-title":"Latest trends in ADHD drug prescribing patterns in children in the UK: prevalence, incidence and persistence.","volume":"6","author":"Beau-Lejdstrom","year":"2016","journal-title":"BMJ Open"},{"key":"zoi210181r156","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12887-015-0435-3","article-title":"Psychostimulant prescribing trends in a paediatric population in Ireland: a national cohort study.","volume":"15","author":"Boland","year":"2015","journal-title":"BMC Pediatr"},{"issue":"9","key":"zoi210181r157","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamapsychiatry.2016.1182","article-title":"Trends in stimulant medication use in commercially insured youths and adults, 2010-2014.","volume":"73","author":"Burcu","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"zoi210181r158","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1087054707299597","article-title":"Trends in medication treatment for ADHD.","volume":"10","author":"Castle","year":"2007","journal-title":"J Atten Disord"},{"issue":"7","key":"zoi210181r159","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1089\/cap.2012.0111","article-title":"Five-fold increase in national prevalence rates of attention-deficit\/hyperactivity disorder medications for children and adolescents with autism spectrum disorder, attention-deficit\/hyperactivity disorder, and other psychiatric disorders: a Danish register-based study.","volume":"23","author":"Dalsgaard","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"12","key":"zoi210181r160","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/00023210-200317120-00005","article-title":"Prevalence of and change in the prescription of methylphenidate in Israel over a 2-year period.","volume":"17","author":"Fogelman","year":"2003","journal-title":"CNS Drugs"},{"issue":"2","key":"zoi210181r161","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1176\/appi.ps.201100095","article-title":"Medication use and spending trends among children with ADHD in Florida\u2019s Medicaid program, 1996-2005.","volume":"63","author":"Fullerton","year":"2012","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi210181r162","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bcpt.2017.120.issue-4","article-title":"Utilization of stimulants and atomoxetine for attention-deficit\/hyperactivity disorder among 5.4 million children using population-based longitudinal data.","volume":"120","author":"Furu","year":"2017","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"zoi210181r163","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00228-020-02948-3","article-title":"The 10-year trend in drug prescriptions for attention-deficit\/hyperactivity disorder (ADHD) in Germany.","volume":"77","author":"Grimmsmann","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"zoi210181r164","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1087054709356386","article-title":"Prevalence of methylphenidate prescription among school-aged children in a Swiss population: increase in the number of prescriptions in the Swiss Canton of Vaud, from 2002 to 2005, and changes in patient demographics.","volume":"14","author":"Gumy","year":"2010","journal-title":"J Atten Disord"},{"issue":"1","key":"zoi210181r165","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1089\/cap.2005.15.62","article-title":"Treatment with stimulants among youths in a large California health plan.","volume":"15","author":"Habel","year":"2005","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"zoi210181r166","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.clinthera.2011.03.001","article-title":"Pharmacologic treatment of attention-deficit\/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands.","volume":"33","author":"Hodgkins","year":"2011","journal-title":"Clin Ther"},{"issue":"5","key":"zoi210181r167","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00228-004-0765-9","article-title":"Increased psychotropic drug consumption by children in the Netherlands during 1995-2001 is caused by increased use of methylphenidate by boys.","volume":"60","author":"Hugtenburg","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"issue":"14","key":"zoi210181r168","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1177\/1087054714528044","article-title":"Changing epidemiology of methylphenidate prescriptions in the community: a multifactorial model.","volume":"21","author":"Jaber","year":"2017","journal-title":"J Atten Disord"},{"issue":"2","key":"zoi210181r169","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.jadohealth.2015.04.009","article-title":"Attention deficit hyperactivity disorder medication use among teens and young adults.","volume":"57","author":"Johansen","year":"2015","journal-title":"J Adolesc Health"},{"issue":"10","key":"zoi210181r170","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1177\/0004867414538675","article-title":"Longitudinal trends in the dispensing of psychotropic medications in Australia from 2009-2012: focus on children, adolescents and prescriber specialty.","volume":"48","author":"Karanges","year":"2014","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"zoi210181r171","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s00228-007-0401-6","article-title":"Prevalence and patterns of methylphenidate use in French children and adolescents.","volume":"64","author":"Knellwolf","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"issue":"16","key":"zoi210181r172","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.4045\/tidsskr.11.1270","article-title":"Prescriptions for ADHD medication, 2004-08.","volume":"132","author":"Lillemoen","year":"2012","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"zoi210181r173","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40199-018-0204-6","article-title":"Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.","volume":"26","author":"Lopez-Leon","year":"2018","journal-title":"Daru"},{"issue":"14","key":"zoi210181r174","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1177\/1087054714536047","article-title":"ADHD drug prescribing trend is increasing among children and adolescents in Hong Kong.","volume":"21","author":"Man","year":"2017","journal-title":"J Atten Disord"},{"key":"zoi210181r175","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1471-2431-12-78","article-title":"The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care.","volume":"12","author":"McCarthy","year":"2012","journal-title":"BMC Pediatr"},{"issue":"2","key":"zoi210181r176","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1177\/1087054717720719","article-title":"Recent trends in the prescribing of ADHD medications in Canadian primary care.","volume":"24","author":"Morkem","year":"2020","journal-title":"J Atten Disord"},{"issue":"6","key":"zoi210181r177","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1176\/appi.ajp.160.6.1071","article-title":"National trends in the treatment of attention deficit hyperactivity disorder.","volume":"160","author":"Olfson","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"10","key":"zoi210181r178","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"zoi210181r179","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bcp.v82.3","article-title":"Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015.","volume":"82","author":"Renoux","year":"2016","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"zoi210181r180","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1067\/mpd.2002.125399","article-title":"Prevalence of methylphenidate use and change over a two-year period: a nationwide study of 2- to 11-year-old Canadian children.","volume":"141","author":"Romano","year":"2002","journal-title":"J Pediatr"},{"issue":"7","key":"zoi210181r181","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1177\/000992288302200707","article-title":"Trends in medication treatment of hyperactive school children: results of six biannual surveys.","volume":"22","author":"Safer","year":"1983","journal-title":"Clin Pediatr (Phila)"},{"key":"zoi210181r182","first-page":"125","article-title":"Trends in medication therapy for hyperactivity: national and international perspectives.","volume":"3","author":"Safer","year":"1984","journal-title":"Adv Learn Behav Disabil"},{"issue":"4, pt 1","key":"zoi210181r183","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.94.4.462","article-title":"The increased rate of stimulant treatment for hyperactive\/inattentive students in secondary schools.","volume":"94","author":"Safer","year":"1994","journal-title":"Pediatrics"},{"key":"zoi210181r184","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1071\/NB02S01","article-title":"Trends in the prescribing of stimulant medication for the treatment of attention deficit hyperactivity disorder in children and adolescents in New South Wales.","volume":"13","author":"Salmelainen","year":"2002","journal-title":"N S W Public Health Bull"},{"issue":"4","key":"zoi210181r185","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/bcp.2009.67.issue-4","article-title":"Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006.","volume":"67","author":"Trip","year":"2009","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"zoi210181r186","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1440-1754.1996.tb01558.x","article-title":"National trends in the use of stimulant medication for attention deficit hyperactivity disorder.","volume":"32","author":"Valentine","year":"1996","journal-title":"J Paediatr Child Health"},{"issue":"3","key":"zoi210181r187","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2165\/00044011-200626030-00006","article-title":"Prevalence of methylphenidate use among Israeli children: 1998-2004.","volume":"26","author":"Vinker","year":"2006","journal-title":"Clin Drug Investig"},{"issue":"3","key":"zoi210181r188","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1177\/1403494820901426","article-title":"Gender- and age-stratified analyses of ADHD medication use in children and adolescents in Finland using population-based longitudinal data, 2008-2018.","volume":"48","author":"Vuori","year":"2020","journal-title":"Scand J Public Health"},{"issue":"1","key":"zoi210181r189","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/pds.3907","article-title":"Impact of negative media publicity on attention-deficit\/hyperactivity disorder medication in Taiwan.","volume":"25","author":"Wang","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"zoi210181r190","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1177\/0009922812441661","article-title":"Clonidine utilization trends for Medicaid children.","volume":"51","author":"Yoon","year":"2012","journal-title":"Clin Pediatr (Phila)"},{"issue":"1","key":"zoi210181r191","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/acps.2013.128.issue-1","article-title":"Stimulant and non-stimulant attention deficit\/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009.","volume":"128","author":"Zetterqvist","year":"2013","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"zoi210181r192","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jama.283.8.1025","article-title":"Trends in the prescribing of psychotropic medications to preschoolers.","volume":"283","author":"Zito","year":"2000","journal-title":"JAMA"},{"issue":"4","key":"zoi210181r193","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1176\/ajp.2006.163.4.579","article-title":"Recent trends in stimulant medication use among U.S. children.","volume":"163","author":"Zuvekas","year":"2006","journal-title":"Am J Psychiatry"},{"key":"zoi210181r194","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jpeds.2018.10.062","article-title":"Longitudinal trends in the diagnosis of attention-deficit\/hyperactivity disorder and stimulant use in preschool children on Medicaid.","volume":"207","author":"Davis","year":"2019","journal-title":"J Pediatr"},{"issue":"2","key":"zoi210181r195","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1176\/appi.ajp.2011.11030387","article-title":"Stimulant medication use in children: a 12-year perspective.","volume":"169","author":"Zuvekas","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"6","key":"zoi210181r196","doi-asserted-by":"publisher","first-page":"508","DOI":"10.3109\/08039480903154534","article-title":"Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.","volume":"63","author":"Janols","year":"2009","journal-title":"Nord J Psychiatry"},{"issue":"1","key":"zoi210181r197","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1089\/cap.2008.0153","article-title":"Trends in incidence and characteristics of children, adolescents, and adults initiating immediate- or extended-release methylphenidate or atomoxetine in the Netherlands during 2001-2006.","volume":"20","author":"van den Ban","year":"2010","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"502","key":"zoi210181r198","first-page":"345","article-title":"Incidence and prevalence of drug-treated attention deficit disorder among boys in the UK.","volume":"54","author":"Jick","year":"2004","journal-title":"Br J Gen Pract"},{"issue":"4","key":"zoi210181r199","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1177\/1087054714553053","article-title":"Psychostimulant prescription for ADHD in new South Wales: a longitudinal perspective.","volume":"19","author":"Prosser","year":"2015","journal-title":"J Atten Disord"},{"issue":"4","key":"zoi210181r200","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1080\/00048670902721129","article-title":"Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006).","volume":"43","author":"Prosser","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"zoi210181r201","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/070674371205700109","article-title":"Ten years of antipsychotic prescribing to children: a Canadian population-based study.","volume":"57","author":"Alessi-Severini","year":"2012","journal-title":"Can J Psychiatry"},{"issue":"4","key":"zoi210181r202","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/pds.2264","article-title":"Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications.","volume":"21","author":"Bruckner","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"zoi210181r203","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1542\/peds.2011-2879","article-title":"Trends of outpatient prescription drug utilization in US children, 2002-2010.","volume":"130","author":"Chai","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"zoi210181r204","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/00048674.2010.543413","article-title":"Australian national trends in stimulant dispensing: 2002-2009.","volume":"45","author":"Hollingworth","year":"2011","journal-title":"Aust N Z J Psychiatry"},{"issue":"14","key":"zoi210181r205","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1087054714523129","article-title":"ADHD medication trends in Turkey: 2009-2013.","volume":"21","author":"\u00d6ner","year":"2017","journal-title":"J Atten Disord"},{"issue":"5","key":"zoi210181r206","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/pds.v23.5","article-title":"Trends in attention deficit hyperactivity disorder drugs consumption, Israel, 2005-2012.","volume":"23","author":"Ponizovsky","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"zoi210181r207","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1377\/hlthaff.26.2.450","article-title":"The global market for ADHD medications.","volume":"26","author":"Scheffler","year":"2007","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"zoi210181r208","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/cap.2014.0071","article-title":"Trends in attention-deficit\/hyperactivity disorder drug consumption in children and adolescents in Slovenia from 2001 to 2012: a drug use study from a national perspective.","volume":"25","author":"\u0160tuhec","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"zoi210181r209","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/pds.2348","article-title":"Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y Le\u00f3n (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.","volume":"21","author":"Trece\u00f1o","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"10","key":"zoi210181r210","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00228-012-1265-y","article-title":"The use of medication against attention deficit hyperactivity disorder in Denmark: a drug use study from a national perspective.","volume":"68","author":"Potteg\u00e5rd","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"zoi210181r211","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2832","article-title":"Attention-deficit\/hyperactivity disorder and psychotropic polypharmacy prescribing trends.","volume":"146","author":"Girand","year":"2020","journal-title":"Pediatrics"},{"issue":"1","key":"zoi210181r212","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1176\/appi.ps.57.1.63","article-title":"Trends in the use of psychotropic medications among adolescents, 1994 to 2001.","volume":"57","author":"Thomas","year":"2006","journal-title":"Psychiatr Serv"},{"issue":"4","key":"zoi210181r213","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1542\/peds.2013-1546","article-title":"National trends in psychotropic medication use in young children: 1994-2009.","volume":"132","author":"Chirdkiatgumchai","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"zoi210181r214","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1055\/s-2008-1064126","article-title":"Social considerations in the labeling of students as attention deficit hyperactivity disordered.","volume":"16","author":"Damico","year":"1995","journal-title":"Semin Speech Lang"},{"issue":"6","key":"zoi210181r215","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/hrp.7.6.334","article-title":"A name, what\u2019s in a name? the medicalization of hyperactivity, revisited.","volume":"7","author":"Klasen","year":"2000","journal-title":"Harv Rev Psychiatry"},{"issue":"4","key":"zoi210181r216","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/cch.12448","article-title":"Educators\u2019 experiences of managing students with ADHD: a qualitative study.","volume":"43","author":"Moore","year":"2017","journal-title":"Child Care Health Dev"},{"issue":"1","key":"zoi210181r217","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12646-014-0288-0","article-title":"Consequences of the \u201cattention-deficit\/hyperactivity disorder\u201d (ADHD) diagnosis. An investigation with education professionals.","volume":"60","author":"Rogalin","year":"2015","journal-title":"Psychol Stud (Mysore)"},{"issue":"8","key":"zoi210181r218","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031570","article-title":"Adolescents\u2019 experiences of being diagnosed with attention deficit hyperactivity disorder: a phenomenological study conducted in Sweden.","volume":"9","author":"Andersson Frondelius","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"zoi210181r219","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1017\/ipm.2018.13","article-title":"The powerless or the empowered? stakeholders\u2019 experiences of diagnosis and treatment for attention-deficit hyperactivity disorder in Ireland.","volume":"35","author":"Carr-Fanning","year":"2018","journal-title":"Ir J Psychol Med"},{"key":"zoi210181r220","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fpsyt.2015.00168","article-title":"Why the diagnosis of attention deficit hyperactivity disorder matters.","volume":"6","author":"Hamed","year":"2015","journal-title":"Front Psychiatry"},{"issue":"4","key":"zoi210181r221","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12402-019-00302-x","article-title":"Stigma and attention-deficit\/hyperactivity disorder: negative perceptions and anger emotional reactions mediate the link between active symptoms and social distance.","volume":"11","author":"Meza","year":"2019","journal-title":"Atten Defic Hyperact Disord"},{"issue":"5","key":"zoi210181r222","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/08856257.2019.1580838","article-title":"The advantages of an ADHD classification from the perspective of teachers.","volume":"34","author":"Wienen","year":"2019","journal-title":"Eur J Spec Needs Educ"},{"issue":"1","key":"zoi210181r223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15348458.2015.988566","article-title":"The rhetorical construction of the AD\/HD subject: managing the self.","volume":"14","author":"Comstock","year":"2015","journal-title":"J Lang Identity Educ"},{"issue":"3","key":"zoi210181r224","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1375\/bech.23.3.177","article-title":"The effects of diagnostic labelling on the implicit theories of attention-deficit\/hyperactivity disorder held by health professionals.","volume":"23","author":"Dryer","year":"2006","journal-title":"Behav Change"},{"issue":"6","key":"zoi210181r225","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.socscimed.2011.03.049","article-title":"A disorder of anger and aggression: children\u2019s perspectives on attention deficit\/hyperactivity disorder in the UK.","volume":"73","author":"Singh","year":"2011","journal-title":"Soc Sci Med"},{"issue":"6","key":"zoi210181r226","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1080\/00220671.1993.9941228","article-title":"Effects of labeling and ADHD behaviors on peer and teacher judgments.","volume":"86","author":"Cornett-Ruiz","year":"1993","journal-title":"J Educ Res"},{"issue":"4","key":"zoi210181r227","first-page":"259","article-title":"Disclosure of attention deficit hyperactivity disorder and its effect on rejection of students by teachers.","volume":"34","author":"Ghanizadeh","year":"2009","journal-title":"Iran J Med Sci"},{"issue":"1","key":"zoi210181r228","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/08856257.2019.1652441","article-title":"What\u2019s in a name: the effect of category labels on teachers\u2019 beliefs.","volume":"35","author":"Gibbs","year":"2020","journal-title":"Eur J Spec Needs Educ"},{"issue":"2","key":"zoi210181r229","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/1367493507076061","article-title":"Children\u2019s attitudes and behavioural intentions towards a peer with symptoms of ADHD: does the addition of a diagnostic label make a difference?","volume":"11","author":"Law","year":"2007","journal-title":"J Child Health Care"},{"key":"zoi210181r230","article-title":"The stigma of ADHD: teacher ratings of labeled students.","author":"Metzger","journal-title":"Sociol Perspect"},{"issue":"1","key":"zoi210181r231","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10578-019-00917-1","article-title":"What differentiates children with ADHD symptoms who do and do not receive a formal diagnosis? results from a prospective longitudinal cohort study.","volume":"51","author":"O\u2019Connor","year":"2020","journal-title":"Child Psychiatry Hum Dev"},{"issue":"1","key":"zoi210181r232","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jsp.2010.10.001","article-title":"Teachers\u2019 and education students\u2019 perceptions of and reactions to children with and without the diagnostic label \u201cADHD.","volume":"49","author":"Ohan","year":"2011","journal-title":"J Sch Psychol"},{"issue":"3","key":"zoi210181r233","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1177\/0038040720909296","article-title":"Relationships between an ADHD diagnosis and future school behaviors among children with mild behavioral problems.","volume":"93","author":"Owens","year":"2020","journal-title":"Sociol Educ"},{"issue":"5","key":"zoi210181r234","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/archpediatrics.2010.40","article-title":"Impact of early school-based screening and intervention programs for ADHD on children\u2019s outcomes and access to services: follow-up of a school-based trial at age 10 years.","volume":"164","author":"Sayal","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"zoi210181r235","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/(ISSN)1520-6807","article-title":"Factors affecting treatment acceptability for psychostimulant medication versus psychoeducational intervention.","volume":"38","author":"Stinnett","year":"2001","journal-title":"Psychol Sch"},{"issue":"2","key":"zoi210181r236","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/1087054709347178","article-title":"Potential impact of ADHD with stimulant medication label on teacher expectations.","volume":"14","author":"Batzle","year":"2010","journal-title":"J Atten Disord"},{"issue":"7","key":"zoi210181r237","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1176\/ps.2009.60.7.950","article-title":"Children\u2019s beliefs about causes of childhood depression and ADHD: a study of stigmatization.","volume":"60","author":"Coleman","year":"2009","journal-title":"Psychiatr Serv"},{"issue":"8","key":"zoi210181r238","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1176\/ps.2010.61.8.811","article-title":"Stigmatizing experiences of parents of children with a new diagnosis of ADHD.","volume":"61","author":"DosReis","year":"2010","journal-title":"Psychiatr Serv"},{"issue":"2","key":"zoi210181r239","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/(ISSN)1520-6807","article-title":"The ADHD label, analogue methodology, and participants\u2019 geographic location on judgments of social and attentional skills.","volume":"41","author":"Koonce","year":"2004","journal-title":"Psychol Sch"},{"issue":"12","key":"zoi210181r240","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1176\/appi.ps.201200578","article-title":"Parents\u2019 stigmatizing attitudes toward psychiatric labels for ADHD and depression.","volume":"64","author":"Ohan","year":"2013","journal-title":"Psychiatr Serv"},{"issue":"3","key":"zoi210181r241","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/cap.2014.0015","article-title":"Neurocognitive performance and behavioral symptoms in patients with attention-deficit\/hyperactivity disorder during twenty-four months of treatment with methylphenidate.","volume":"25","author":"Wang","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"zoi210181r242","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2013.10.005","article-title":"Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit\/hyperactivity disorder: evidence from a systematic review and a meta-analysis.","volume":"76","author":"Coghill","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"6","key":"zoi210181r243","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1016\/j.ridd.2012.06.003","article-title":"Motor skills of children newly diagnosed with attention deficit hyperactivity disorder prior to and following treatment with stimulant medication.","volume":"33","author":"Brossard-Racine","year":"2012","journal-title":"Res Dev Disabil"},{"issue":"7","key":"zoi210181r244","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2017.0691","article-title":"Educational and health outcomes of children treated for attention-deficit\/hyperactivity disorder.","volume":"171","author":"Fleming","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi210181r245","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/BF00917798","article-title":"A four-year follow-up study of the effects of methylphenidate on the behavior and academic achievement of hyperactive children.","volume":"9","author":"Charles","year":"1981","journal-title":"J Abnorm Child Psychol"},{"issue":"2","key":"zoi210181r246","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/DBP.0000000000000124","article-title":"Improved but still impaired: symptom-impairment correspondence among youth with attention-deficit hyperactivity disorder receiving community-based care.","volume":"36","author":"O'Connor","year":"2015","journal-title":"J Dev Behav Pediatr"},{"issue":"5","key":"zoi210181r247","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cpr.2007.10.007","article-title":"Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis.","volume":"28","author":"Van der Oord","year":"2008","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"zoi210181r248","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/DBP.0b013e3180cabc28","article-title":"Modifiers of long-term school outcomes for children with attention-deficit\/hyperactivity disorder: does treatment with stimulant medication make a difference? results from a population-based study.","volume":"28","author":"Barbaresi","year":"2007","journal-title":"J Dev Behav Pediatr"},{"issue":"2","key":"zoi210181r249","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00787-018-1106-3","article-title":"Does methylphenidate improve academic performance? a systematic review and meta-analysis.","volume":"28","author":"Kortekaas-Rijlaarsdam","year":"2019","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210181r250","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10567-012-0117-8","article-title":"Does long-term medication use improve the academic outcomes of youth with attention-deficit\/hyperactivity disorder?","volume":"15","author":"Langberg","year":"2012","journal-title":"Clin Child Fam Psychol Rev"},{"issue":"4","key":"zoi210181r251","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00787-012-0346-x","article-title":"How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? a systematic review and meta-analysis.","volume":"22","author":"Prasad","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r252","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1542\/peds.2008-1597","article-title":"Positive association between attention-deficit\/ hyperactivity disorder medication use and academic achievement during elementary school.","volume":"123","author":"Scheffler","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"zoi210181r253","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1542\/peds.2011-3493","article-title":"A population-based study of stimulant drug treatment of ADHD and academic progress in children.","volume":"130","author":"Zo\u00ebga","year":"2012","journal-title":"Pediatrics"},{"issue":"4","key":"zoi210181r254","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jaac.2018.11.014","article-title":"Attention-deficit\/hyperactivity disorder, school performance, and effect of medication.","volume":"58","author":"Jangmo","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"zoi210181r255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207905","article-title":"Medical treatment of attention deficit\/hyperactivity disorder (ADHD) and children\u2019s academic performance.","volume":"13","author":"Keilow","year":"2018","journal-title":"PLoS One"},{"key":"zoi210181r256","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jhealeco.2014.05.002","article-title":"Do stimulant medications improve educational and behavioral outcomes for children with ADHD?","volume":"37","author":"Currie","year":"2014","journal-title":"J Health Econ"},{"issue":"1","key":"zoi210181r257","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ambp.2005.08.005","article-title":"Emergency department use and costs for youth with attention-deficit\/hyperactivity disorder: associations with stimulant treatment.","volume":"6","author":"Leibson","year":"2006","journal-title":"Ambul Pediatr"},{"issue":"2","key":"zoi210181r258","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00787-013-0432-8","article-title":"Association between ADHD drug use and injuries among children and adolescents.","volume":"23","author":"van den Ban","year":"2014","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"8","key":"zoi210181r259","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S2215-0366(15)00271-0","article-title":"Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study.","volume":"2","author":"Dalsgaard","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"zoi210181r260","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/injuryprev-2012-040483","article-title":"Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design.","volume":"19","author":"Raman","year":"2013","journal-title":"Inj Prev"},{"key":"zoi210181r261","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neubiorev.2017.11.007","article-title":"Risk of unintentional injuries in children and adolescents with ADHD and the impact of ADHD medications: a systematic review and meta-analysis.","volume":"84","author":"Ruiz-Goikoetxea","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"zoi210181r262","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1007\/s00198-016-3547-1","article-title":"Medication therapy for attention deficit\/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.","volume":"27","author":"Perry","year":"2016","journal-title":"Osteoporos Int"},{"key":"zoi210181r263","article-title":"The association between attention-deficit hyperactivity disorder, injuries, and methylphenidate.","volume":"6","author":"Shem-Tov","year":"2019","journal-title":"Glob Pediatr Health"},{"issue":"4","key":"zoi210181r264","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1001\/jamapediatrics.2014.3275","article-title":"Injury prevention by medication among children with attention-deficit\/hyperactivity disorder: a case-only study.","volume":"169","author":"Mikolajczyk","year":"2015","journal-title":"JAMA Pediatr"},{"key":"zoi210181r265","article-title":"Medication use for ADHD and the risk of driving citations and crashes among teenage drivers: a population-based cohort study.","volume":"1087054720915768","author":"Winterstein","year":"2020","journal-title":"J Atten Disord"},{"issue":"3","key":"zoi210181r266","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/15563650.2013.772623","article-title":"Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit\/hyperactivity disorder drugs in the United States.","volume":"51","author":"Levine","year":"2013","journal-title":"Clin Toxicol (Phila)"},{"key":"zoi210181r267","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2147\/NDT","article-title":"Blood pressure and anthropometry in children treated with stimulants: a longitudinal cohort study with an individual approach.","volume":"13","author":"Landgren","year":"2017","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"zoi210181r268","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1176\/appi.ajp.2011.10111705","article-title":"Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.","volume":"169","author":"Vitiello","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"20","key":"zoi210181r269","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJMoa1110212","article-title":"ADHD drugs and serious cardiovascular events in children and young adults.","volume":"365","author":"Cooper","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi210181r270","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1542\/peds.2010-3371","article-title":"Cardiovascular events and death in children exposed and unexposed to ADHD agents.","volume":"127","author":"Schelleman","year":"2011","journal-title":"Pediatrics"},{"key":"zoi210181r271","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4627","article-title":"Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study.","volume":"345","author":"Winterstein","year":"2012","journal-title":"BMJ"},{"key":"zoi210181r272","doi-asserted-by":"publisher","first-page":"i2550","DOI":"10.1136\/bmj.i2550","article-title":"Cardiovascular safety of methylphenidate among children and young people with attention-deficit\/hyperactivity disorder (ADHD): nationwide self controlled case series study.","volume":"353","author":"Shin","year":"2016","journal-title":"BMJ"},{"issue":"6","key":"zoi210181r273","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1089\/cap.2014.0020","article-title":"Cardiovascular safety of stimulants in children with attention-deficit\/hyperactivity disorder: a nationwide prospective cohort study.","volume":"24","author":"Dalsgaard","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"zoi210181r274","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1471-2261-12-41","article-title":"Do prescription stimulants increase the risk of adverse cardiovascular events? a systematic review.","volume":"12","author":"Westover","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"issue":"7","key":"zoi210181r275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180355","article-title":"The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials.","volume":"12","author":"Catal\u00e1-L\u00f3pez","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"zoi210181r276","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00213-007-0840-x","article-title":"Efficacy and safety of atomoxetine for attention-deficit\/hyperactivity disorder in children and adolescents\u2014meta-analysis and meta-regression analysis.","volume":"194","author":"Cheng","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"issue":"1","key":"zoi210181r277","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/00004703-200202001-00002","article-title":"Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment.","volume":"23","author":"Connor","year":"2002","journal-title":"J Dev Behav Pediatr"},{"issue":"9","key":"zoi210181r278","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis.","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"zoi210181r279","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12402-017-0216-y","article-title":"Atomoxetine treatment for children and adolescents with attention-deficit\/hyperactivity disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology.","volume":"9","author":"Gayleard","year":"2017","journal-title":"Atten Defic Hyperact Disord"},{"issue":"2","key":"zoi210181r280","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaac.2013.11.009","article-title":"Alpha-2 agonists for attention-deficit\/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.","volume":"53","author":"Hirota","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi210181r281","first-page":"0312","article-title":"ADHD in children and adolescents.","volume":"2011","author":"Keen","year":"2011","journal-title":"BMJ Clin Evid"},{"issue":"23","key":"zoi210181r282","doi-asserted-by":"publisher","first-page":"iii","DOI":"10.3310\/hta10230","article-title":"A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.","volume":"10","author":"King","year":"2006","journal-title":"Health Technol Assess"},{"issue":"10","key":"zoi210181r283","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1177\/070674379904401007","article-title":"Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies.","volume":"44","author":"Klassen","year":"1999","journal-title":"Can J Psychiatry"},{"issue":"1","key":"zoi210181r284","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087054714559643","article-title":"Long-term efficacy of methylphenidate immediate-release for the treatment of childhood ADHD.","volume":"21","author":"Maia","year":"2017","journal-title":"J Atten Disord"},{"key":"zoi210181r285","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.2147\/DDDT","article-title":"Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials.","volume":"9","author":"Maneeton","year":"2015","journal-title":"Drug Des Dev Ther"},{"issue":"12","key":"zoi210181r286","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2165\/11201140-000000000-00000","article-title":"Dexmethylphenidate extended release: a review of its use in the treatment of attention-deficit hyperactivity disorder.","volume":"23","author":"Moen","year":"2009","journal-title":"CNS Drugs"},{"issue":"9","key":"zoi210181r287","article-title":"Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.","author":"Otasowie","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi210181r288","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/PRBM","article-title":"The long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trials.","volume":"6","author":"Parker","year":"2013","journal-title":"Psychol Res Behav Manag"},{"key":"zoi210181r289","article-title":"Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents.","volume":"2","author":"Punja","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"zoi210181r290","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00213-017-4662-1","article-title":"Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.","volume":"234","author":"Riera","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"zoi210181r291","first-page":"1475","article-title":"How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? a meta-analysis.","volume":"165","author":"Schachter","year":"2001","journal-title":"CMAJ"},{"issue":"2","key":"zoi210181r292","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaac.2013.11.005","article-title":"Efficacy and safety of atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression.","volume":"53","author":"Schwartz","year":"2014","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"zoi210181r293","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.cpr.2014.02.001","article-title":"Pharmacological and psychosocial treatments for adolescents with ADHD: an updated systematic review of the literature.","volume":"34","author":"Sibley","year":"2014","journal-title":"Clin Psychol Rev"},{"issue":"11","key":"zoi210181r294","article-title":"Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).","author":"Storeb\u00f8","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi210181r295","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/NDT","article-title":"Response to methylphenidate by adult and pediatric patients with attention-deficit\/hyperactivity disorder: the Spanish multicenter DIHANA study.","volume":"9","author":"Valdiz\u00e1n-Us\u00f3n","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"zoi210181r296","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1017\/S0033291718000545","article-title":"Long-term effects of stimulant treatment on ADHD symptoms, social-emotional functioning, and cognition.","volume":"49","author":"Schweren","year":"2019","journal-title":"Psychol Med"},{"issue":"6","key":"zoi210181r297","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jcpp.12684","article-title":"Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit\/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.","volume":"58","author":"Swanson","year":"2017","journal-title":"J Child Psychol Psychiatry"},{"issue":"9","key":"zoi210181r298","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00787-016-0820-y","article-title":"A 6-year follow-up of a large European cohort of children with attention-deficit\/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood.","volume":"25","author":"van Lieshout","year":"2016","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r299","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1097\/00004583-200405000-00009","article-title":"Stimulant treatment over five years: adherence, effectiveness, and adverse effects.","volume":"43","author":"Charach","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2 pt 1","key":"zoi210181r300","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0022-3476(99)70023-5","article-title":"Stimulant medications decrease energy expenditure and physical activity in children with attention-deficit\/hyperactivity disorder.","volume":"135","author":"Butte","year":"1999","journal-title":"J Pediatr"},{"issue":"10","key":"zoi210181r301","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/oby.21949","article-title":"ADHD medication, dietary patterns, physical activity, and BMI in children: a longitudinal analysis of the ECLS-K study.","volume":"25","author":"Bowling","year":"2017","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"zoi210181r302","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/YIC.0000000000000109","article-title":"Stimulant medication effects on growth and bone age in children with attention-deficit\/hyperactivity disorder: a prospective cohort study.","volume":"31","author":"Poulton","year":"2016","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"zoi210181r303","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0030-1261893","article-title":"Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.","volume":"41","author":"Zhang","year":"2010","journal-title":"Neuropediatrics"},{"issue":"8","key":"zoi210181r304","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/cap.2016.0150","article-title":"Weight, height, and body mass index in patients with attention-deficit\/hyperactivity disorder treated with methylphenidate.","volume":"27","author":"D\u00edez-Su\u00e1rez","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"9","key":"zoi210181r305","first-page":"994","article-title":"Effect of stimulants on height and weight: a review of the literature.","volume":"47","author":"Faraone","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"5","key":"zoi210181r306","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1515\/JPEM.2003.16.5.711","article-title":"Daily methylphenidate use slows the growth of children: a community based study.","volume":"16","author":"Lisska","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"8","key":"zoi210181r307","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1136\/adc.2004.056952","article-title":"Growth on stimulant medication; clarifying the confusion: a review.","volume":"90","author":"Poulton","year":"2005","journal-title":"Arch Dis Child"},{"key":"zoi210181r308","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13034-015-0082-3","article-title":"The effects of long-term medication on growth in children and adolescents with ADHD: an observational study of a large cohort of real-life patients.","volume":"9","author":"Powell","year":"2015","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"4","key":"zoi210181r309","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1542\/peds.2014-0428","article-title":"ADHD, stimulant treatment, and growth: a longitudinal study.","volume":"134","author":"Harstad","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"zoi210181r310","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ridd.2004.12.004","article-title":"Effects of long-term psychostimulant medication on growth of children with ADHD.","volume":"27","author":"Zachor","year":"2006","journal-title":"Res Dev Disabil"},{"issue":"12","key":"zoi210181r311","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1056\/NEJMoa1813751","article-title":"Psychosis with methylphenidate or amphetamine in patients with ADHD.","volume":"380","author":"Moran","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"zoi210181r312","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00004583-200008000-00009","article-title":"Stimulant treatment for children: a community perspective.","volume":"39","author":"Angold","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"zoi210181r313","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1542\/peds.111.1.97","article-title":"Does the treatment of attention-deficit\/hyperactivity disorder with stimulants contribute to drug use\/abuse? a 13-year prospective study.","volume":"111","author":"Barkley","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"zoi210181r314","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1176\/appi.ajp.2007.07091486","article-title":"Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.","volume":"165","author":"Biederman","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"7","key":"zoi210181r315","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1001\/jamapsychiatry.2013.1273","article-title":"Stimulant medication and substance use outcomes: a meta-analysis.","volume":"70","author":"Humphreys","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"zoi210181r316","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00702-008-0872-3","article-title":"No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit\/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study.","volume":"115","author":"Huss","year":"2008","journal-title":"J Neural Transm (Vienna)"},{"issue":"2","key":"zoi210181r317","doi-asserted-by":"crossref","DOI":"10.1542\/peds.104.2.e20","article-title":"Pharmacotherapy of attention-deficit\/hyperactivity disorder reduces risk for substance use disorder.","volume":"104","author":"Biederman","year":"1999","journal-title":"Pediatrics"},{"issue":"2","key":"zoi210181r318","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1192\/bjp.bp.112.124784","article-title":"Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.","volume":"203","author":"Groenman","year":"2013","journal-title":"Br J Psychiatry"},{"issue":"5","key":"zoi210181r319","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1176\/appi.ajp.2008.07091465","article-title":"Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: prospective follow-up into adulthood.","volume":"165","author":"Mannuzza","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"10","key":"zoi210181r320","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1001\/archpedi.162.10.916","article-title":"Effect of prior stimulant treatment for attention-deficit\/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.","volume":"162","author":"Wilens","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"zoi210181r321","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1542\/peds.111.1.179","article-title":"Does stimulant therapy of attention-deficit\/hyperactivity disorder beget later substance abuse? a meta-analytic review of the literature.","volume":"111","author":"Wilens","year":"2003","journal-title":"Pediatrics"},{"key":"zoi210181r322","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.2147\/CLEP","article-title":"Overuse of methylphenidate: an analysis of Swedish pharmacy dispensing data.","volume":"10","author":"Bjerkeli","year":"2018","journal-title":"Clin Epidemiol"},{"issue":"3","key":"zoi210181r323","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1542\/peds.2008-0931","article-title":"Adolescent prescription ADHD medication abuse is rising along with prescriptions for these medications.","volume":"124","author":"Setlik","year":"2009","journal-title":"Pediatrics"},{"issue":"1","key":"zoi210181r324","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/chi.0b013e31815a56f1","article-title":"Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature.","volume":"47","author":"Wilens","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"zoi210181r325","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.eurpsy.2016.06.005","article-title":"Use of atomoxetine and suicidal ideation in children and adolescents: results of an observational cohort study within general practice in England.","volume":"39","author":"Davies","year":"2017","journal-title":"Eur Psychiatry"},{"issue":"10","key":"zoi210181r326","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2017.2183","article-title":"Association of risk of suicide attempts with methylphenidate treatment.","volume":"74","author":"Man","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"zoi210181r327","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.biopsych.2019.12.003","article-title":"Medication for attention-deficit\/hyperactivity disorder and risk for suicide attempts.","volume":"88","author":"Chang","year":"2020","journal-title":"Biol Psychiatry"},{"key":"zoi210181r328","doi-asserted-by":"publisher","first-page":"g3769","DOI":"10.1136\/bmj.g3769","article-title":"Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study.","volume":"348","author":"Chen","year":"2014","journal-title":"BMJ"},{"key":"zoi210181r329","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ridd.2017.10.023","article-title":"Suicide risk reduction in youths with attention-deficit\/hyperactivity disorder prescribed methylphenidate: a Taiwan nationwide population-based cohort study.","volume":"72","author":"Liang","year":"2018","journal-title":"Res Dev Disabil"},{"issue":"11","key":"zoi210181r330","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2165\/11317630-000000000-00000","article-title":"Mortality associated with attention-deficit hyperactivity disorder (ADHD) drug treatment: a retrospective cohort study of children, adolescents and young adults using the general practice research database.","volume":"32","author":"McCarthy","year":"2009","journal-title":"Drug Saf"},{"issue":"6","key":"zoi210181r331","doi-asserted-by":"publisher","first-page":"e648","DOI":"10.4088\/JCP.15r10601","article-title":"Risk of irritability with psychostimulant treatment in children with ADHD: a meta-analysis.","volume":"78","author":"Stuckelman","year":"2017","journal-title":"J Clin Psychiatry"},{"key":"zoi210181r332","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jad.2018.05.021","article-title":"Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: a meta-analysis.","volume":"238","author":"Pozzi","year":"2018","journal-title":"J Affect Disord"},{"issue":"4","key":"zoi210181r333","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaac.2018.11.016","article-title":"Attention-deficit\/hyperactivity disorder in childhood and adolescence and the risk of crime in young adulthood in a Danish nationwide study.","volume":"58","author":"Mohr-Jensen","year":"2019","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"zoi210181r334","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00787-017-0986-y","article-title":"Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit\/hyperactivity disorder.","volume":"26","author":"Coghill","year":"2017","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"4","key":"zoi210181r335","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11126-011-9172-4","article-title":"Improvement in global psychopathology increases quality of life during treatment of ADHD with atomoxetine or stimulants.","volume":"82","author":"Bastiaens","year":"2011","journal-title":"Psychiatr Q"},{"issue":"10","key":"zoi210181r336","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2165\/11537450-000000000-00000","article-title":"The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review.","volume":"24","author":"Coghill","year":"2010","journal-title":"CNS Drugs"},{"issue":"1","key":"zoi210181r337","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1087054710381480","article-title":"A 12-month prospective, observational study of treatment regimen and quality of life associated with ADHD in central and eastern Europe and eastern Asia.","volume":"16","author":"Goetz","year":"2012","journal-title":"J Atten Disord"},{"issue":"1","key":"zoi210181r338","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/157488607779315444","article-title":"Attention deficit and hyperactivity disorder: controversies of diagnosis and safety of pharmacological and nonpharmacological treatment.","volume":"2","author":"Benner-Davis","year":"2007","journal-title":"Curr Drug Saf"},{"issue":"7","key":"zoi210181r339","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1001\/jamapediatrics.2019.0905","article-title":"Evaluation of methylphenidate safety and maximum-dose titration rationale in attention-deficit\/hyperactivity disorder: a meta-analysis.","volume":"173","author":"Ching","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"9","key":"zoi210181r340","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/archdischild-2013-304170","article-title":"Safety of medicines used for ADHD in children: a review of published prospective clinical trials.","volume":"99","author":"Clavenna","year":"2014","journal-title":"Arch Dis Child"},{"issue":"10","key":"zoi210181r341","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s00228-011-1050-3","article-title":"One-year prospective follow-up of pharmacological treatment in children with attention-deficit\/hyperactivity disorder.","volume":"67","author":"Didoni","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"zoi210181r342","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178187","article-title":"Gastrointestinal adverse events during methylphenidate treatment of children and adolescents with attention deficit hyperactivity disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.","volume":"12","author":"Holmskov","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"zoi210181r343","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/cap.2010.0152","article-title":"Age-grouped differences in adverse drug events from psychotropic medication.","volume":"21","author":"Safer","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"zoi210181r344","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/1574887111308010002","article-title":"Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials.","volume":"8","author":"Ghanizadeh","year":"2013","journal-title":"Rev Recent Clin Trials"},{"key":"zoi210181r345","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.2147\/NDT","article-title":"Changes in behavior as side effects in methylphenidate treatment: review of the literature.","volume":"12","author":"Konrad-Bindl","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"zoi210181r346","article-title":"Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.","volume":"5","author":"Storeb\u00f8","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"zoi210181r347","doi-asserted-by":"publisher","first-page":"e1459","DOI":"10.4088\/JCP.14r09478","article-title":"Examining why patients with attention-deficit\/hyperactivity disorder lack adherence to medication over the long term: a review and analysis.","volume":"76","author":"Frank","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"zoi210181r348","first-page":"1543","article-title":"Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder\u2014a systematic literature review.","volume":"10","author":"Gajria","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"2","key":"zoi210181r349","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116407","article-title":"Effect of treatment modality on long-term outcomes in attention-deficit\/hyperactivity disorder: a systematic review.","volume":"10","author":"Arnold","year":"2015","journal-title":"PLoS One"},{"key":"zoi210181r350","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jpsychires.2020.01.006","article-title":"A literature review and meta-analysis on the effects of ADHD medications on functional outcomes.","volume":"123","author":"Boland","year":"2020","journal-title":"J Psychiatr Res"},{"issue":"5","key":"zoi210181r351","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.biopsych.2019.04.009","article-title":"Risks and benefits of attention-deficit\/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases.","volume":"86","author":"Chang","year":"2019","journal-title":"Biol Psychiatry"},{"issue":"4","key":"zoi210181r352","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1177\/070674370204700404","article-title":"Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies.","volume":"47","author":"Schachar","year":"2002","journal-title":"Can J Psychiatry"},{"issue":"2","key":"zoi210181r353","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5455\/bcp.20120412021635","article-title":"Treatment duration is associated with functioning and prognosis in children with attention deficit hyperactivity disorder.","volume":"22","author":"Ercan","year":"2012","journal-title":"Klinik Psikofarmakoloji Bulteni"},{"issue":"4","key":"zoi210181r354","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1542\/peds.113.4.762","article-title":"National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment.","volume":"113","author":"MTA Cooperative Group","year":"2004","journal-title":"Pediatrics"},{"issue":"5","key":"zoi210181r355","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/CHI.0b013e31819c23d0","article-title":"The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.","volume":"48","author":"Molina","year":"2009","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi210181r357","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s007870170036","article-title":"Is clinic prevalence of ICD-10 hyperkinesis underestimated? impact of increasing awareness by a questionnaire screen in an UK clinic.","volume":"10","author":"Foreman","year":"2001","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"11","key":"zoi210181r358","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamapsychiatry.2019.1956","article-title":"Temporal changes in effect sizes of studies comparing individuals with and without autism: a meta-analysis.","volume":"76","author":"R\u00f8dgaard","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"10090","key":"zoi210181r359","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0140-6736(16)32586-7","article-title":"Levers for addressing medical underuse and overuse: achieving high-value health care.","volume":"390","author":"Elshaug","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"zoi210181r361","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative Versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS).","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"zoi210181r27","author":"Peters","year":"2020"},{"key":"zoi210181r32","author":"Moola","year":"2020"},{"key":"zoi210181r58","volume-title":"Reported Diagnosis and Prescription Utilization Related to Attention Deficit Hyperactivity Disorder in Children Ages 5-17, 2008-2015","author":"Anderson","year":"2001"},{"key":"zoi210181r356","volume-title":"Raine ADHD Study: Long-term Outcomes Associated With Stimulant Medication in the Treatment of ADHD in Children","author":"Smith","year":"2010"},{"key":"zoi210181r360","unstructured":"Baker? J. Schools must prepare for 50 per cent rise in students with disabilities: report. The Sydney Morning Herald. February 9, 2020. Accessed March 5, 2021. https:\/\/www.smh.com.au\/national\/nsw\/schools-must-prepare-for-50-per-cent-rise-in-students-with-disabilities-report-20200902-p55rrm.html"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2778451\/kazda_2021_oi_210181_1617638221.87116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T22:29:12Z","timestamp":1671834552000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2778451"}},"subtitle":["A Systematic Scoping Review"],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":361,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.5335","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]}}}